Importantly, analogous conclusions were made by investigators who used anti-CD45 mAbs for capture of mononuclear cell-derived CD45(+) exosomes and their separation from tumor-enriched CD45(−) sEV [18]. The gene discussed is PTPRC; the disease is neoplasm.